Tiziana Life Sciences Ltd
TLSA
$2.04
-$0.09-4.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.84M | -12.35M | -11.86M | -12.80M | -13.73M |
| Total Depreciation and Amortization | 150.00K | 137.00K | 124.00K | 113.50K | 103.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.87M | 9.32M | 10.77M | 7.60M | 4.43M |
| Change in Net Operating Assets | -3.93M | -2.24M | -552.00K | 2.37M | 5.29M |
| Cash from Operations | -8.75M | -5.14M | -1.53M | -2.72M | -3.91M |
| Capital Expenditure | -11.00K | -15.00K | -19.00K | -16.50K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.89M | 1.44M | -- | -500.00K | -1.00M |
| Cash from Investing | 2.88M | 1.43M | -19.00K | -516.50K | -1.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -120.00K | -130.50K | -141.00K | -146.00K | -151.00K |
| Issuance of Common Stock | 12.05M | 8.35M | 4.65M | 2.34M | 25.00K |
| Repurchase of Common Stock | -52.00K | -52.00K | -52.00K | -26.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 67.50K | 135.00K |
| Cash from Financing | 11.88M | 8.17M | 4.45M | 2.23M | 9.00K |
| Foreign Exchange rate Adjustments | 113.00K | -127.00K | -367.00K | -461.50K | -556.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.12M | 4.33M | 2.54M | -1.46M | -5.47M |